Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Liqin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0607-9728; OpenAlex author ID A5101442916. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 4

  1. WITHDRAWN: Exogenous HMGB1 promotes pancreatic cancer progression by supporting the crosstalk between tumor and myeloid-derived suppressor cell Co-author DOI 10.21203/rs.3.rs-3886646/v1↗
  2. The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ygeno.2021.11.036↗
  3. Multimodal data analysis reveals that pancreatobiliary-type ampullary adenocarcinoma resembles pancreatic adenocarcinoma and differs from cholangiocarcinoma. Co-author DOI 10.1186/s12967-022-03473-w↗
  4. Predictive dosimetric parameters for gastrointestinal toxicity with hypofractioned radiotherapy in pancreatic adenocarcinoma. Last author DOI 10.2147/ott.s102035↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yize Mao · 2 shared papers, 2022 · strength 0.29
  2. Shengping Li · 2 shared papers, 2022 · strength 0.29
  3. Faming Wang · 1 shared paper, 2024 · strength 0.28
  4. Wei Wei · 1 shared paper, 2024 · strength 0.28
  5. Ning Wang · 1 shared paper, 2024 · strength 0.28
  6. Wei Wang · 1 shared paper, 2022 · strength 0.15
  7. Qiuxia Yang · 1 shared paper, 2022 · strength 0.15
  8. Jun Cheng · 1 shared paper, 2022 · strength 0.14
  9. Wei Wang · 1 shared paper, 2022 · strength 0.14
  10. Xian Liu · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.